Awards

Anseth earns international recognition with L’Oreal-UNESCO For Women in Science award

Anonymous — Tue, 18 Feb 2020 17:21:16 +0000

Anseth earns international recognition with L’Oreal-UNESCO For Women in Science award Anonymous (not verified) Tue, 02/18/2020 - 10:21

Jonathan Raab

�� Boulder Professor Kristi Anseth has received one of the most prestigious recognitions in the life sciences: a L’Oreal-UNESCO For Women in Science award.

Anseth, a distinguished professor and Tisone professor in the Department of Chemical and Biological Engineering, is being recognized for her “outstanding contribution in converging engineering and biology to develop innovative biomaterials that help tissue regeneration and drug delivery,” according to UNESCO.

She is one of only five women in the world, and the only recipient in North America, to receive the recognition this year.

“I am tremendously honored and feel so very fortunate to be part of the broader University of Colorado community,” Anseth said. “However, I must first acknowledge that this is a shared honor. I have the pleasure of mentoring an amazing group of undergraduate students, graduate students and postdoctoral associates in my laboratory, and these individuals have contributed tremendously to the basis for this recognition. I am so thankful to them for their dedication and ��’s commitment to supporting not only the education of these individuals but their transition to future leaders.”

Anseth said she’s eagerly anticipating the opportunity to celebrate women scientists and engineers and to play a more visible role for the next generation. The mother of a 12-year-old daughter, Anseth said she hopes her daughter’s generation is inspired to pursue careers in STEM and that girls see no bounds to their possible careers.

She also commended her colleagues in the Department of Chemical and Biological Engineering and the BIoFrontiers Institute for their support.

“I am fortunate to work in an environment with such brilliant colleagues who work tirelessly to advance our fields and educate students to develop technologies and ideas for supporting the well-being of people, society and the planet,” Anseth said.

Anseth, who is also the associate director of the BioFrontiers Institute, has a long and storied career in applying the principles of chemical engineering to the biomaterials field, authoring over 330 papers of extensive, highly impactful research and earning numerous awards and recognitions. She is one of only a handful of individuals worldwide elected to all three national academies: the National Academy of Engineering, the National Academy of Medicine and the National Academy of Sciences. She also has been elected to the American Academy of Arts and Sciences, the National Academy of Inventors and the International Academy of Medical and Biological Engineering.

“Professor Anseth has proven time and again, through her stellar career of research and achievement, as well as her teaching and mentoring, that she is a world-class scientist and engineer,” said Keith Molenar, interim dean of the College of Engineering and Applied Science. “The L’Oreal-UNESCO For Women in Science awards recognize the best of the best, and she is absolutely deserving of that honor. We’re proud that she calls the �� Boulder College of Engineering and Applied Science home, as she brings immeasurable value to the research and education happening here.”

“Kristi Anseth has been a leader in cutting-edge biomaterials research for over two decades,” said Charles Musgrave, chair of the Department of Chemical and Biological Engineering. “Her work in the tissue engineering and drug delivery fields has led to the development of key technologies that will have an incredible impact on regenerative medicine and drug delivery. I can’t think of anyone more deserving of this award than her. My colleagues and I are proud of her many accomplishments.”

Anseth earned her doctoral degree in chemical engineering from �� Boulder in 1994 and joined the faculty shortly thereafter, focusing her research on developing biomaterials for medical applications.

Rob Davis, dean emeritus of the College of Engineering and Applied Science and Tisone endowed chair in the Department of Chemical and Biological Engineering, nominated Anseth for the award. He cited her unparalleled research accomplishments in biotechnology and cell biology and the translation of her technologies into medical products, including in-situ-forming materials for enhanced bone regeneration, hydrogels for chondrocyte delivery and more.

He also emphasized her dedication to her students, recalling his first observation of her after she completed her PhD. She had volunteered to teach an 8 a.m. undergraduate course, winning over the sleepy and skeptical students with her enthusiasm and passion for the material.

Support for the nomination also came from other distinguished leaders in academia, including professors Paula T. Hammond and Robert Langer of MIT, Provost David A. Tirrell and Professor Mark E. Davis of the California Institute of Technology, and Professor Nicholas A. Peppas of the University of Texas at Austin.

The international For Women in Science awards, now in their 22nd year, recognize the accomplishments of women who work in the biotechnology, ecology, epigenetics, epidemiology and infectiology research fields. The L’Oreal Foundation and UNESCO bestow five of these awards each year, recognizing one researcher each from Africa and the Arab States, the Asia-Pacific region, Europe, Latin America and North America. Fifteen additional “Rising Talents” are recognized from these regions as well.

Anseth and the other awardees will be honored at a ceremony March 12 at UNESCO Headquarters in Paris. Each award recipient will receive €100,000 (about $109,000). The awards seek to increase the representation and awareness of women in science and their achievements to inspire more women to consider careers in the sciences.

The late Deborah Jin, a professor of physics and JILA fellow at �� Boulder, also received the award in 2012.

Off

Traditional

White

Yuanyuan Xie awarded National Cancer Center fellowship to explore the pathological role of transposons

Anonymous — Wed, 12 Jun 2019 14:56:18 +0000

Yuanyuan Xie awarded National Cancer Center fellowship to explore the pathological role of transposons Anonymous (not verified) Wed, 06/12/2019 - 08:56

Lindsay Diamond

Nearly all species’ genomes are littered with millions of genetic sequences called transposons, which are virus-like parasitic elements that can replicate and spread within host genomes. Collectively, transposon-derived sequences constitute about 50 percent of the human genome sequence, and are believed to have - over tens of millions of years - played a critical role in our evolution. Transposons are increasingly recognized to have influenced human biology and adaptation, particularly in the realms of development and immunity. Transposons may also contribute to disease.

Yuanyuan Xie, a postdoctoral researcher in the Chuong Lab, was recently awarded a National Cancer Center Postdoctoral Fellowship to explore the pathological role of transposon-derived sequences known as retrocopies in colorectal cancer.

For the cell to create proteins, the DNA sequence of a gene is transcribed into RNA, which is then normally translated into a protein. However, cellular RNAs are occasionally reverse-transcribed back to DNA and inserted into a different location in the genome, forming a type of gene duplication known as a retrocopy. Retrocopies originate from the activity of retrotransposons, which replicate by reverse transcribing their own RNA into host DNA, but occasionally capture cellular RNAs by accident. While over 8,000 retrocopies can be detected in the human genome, they are often assumed to be nonfunctional. Nevertheless, genomic studies have revealed that many retrocopies have transcribed RNAs or even translated proteins, often with distinct activities from their parental genes.

Repeat sequences can have deleterious effects in the genome and underlie several human disease conditions including Huntington’s disease, fragile X syndrome, several ataxias, and myotonic dystrophy. To protect against potential harm, all organisms have evolved genomic defenses to repress transposons through epigenetic manipulation. Yet, repression is inherently reversible, and inappropriate reactivation of transposons are common in many cancers. However, the specific cellular functions of retrocopies and whether they play a genome-wide role in cancer progression remain unknown.

Answering these questions is what drew Yuanyuan to the interdisciplinarity of Chuong Lab and the BioFrontiers Institute. “My previous experience was in cell signaling pathways and stem cell models, and I was interested in joining the Chuong Lab where I can learn computational genomics to study gene regulatory networks in evolution and disease,” says Xie.

Taking a break from the bench, Yuanyuan scoured The Cancer Genome Atlas (TCGA), a joint effort between the National Cancer Institute and the National Human Genome Research Institute that has characterized over 20,000 primary cancer and normal samples across a variety of different cancers, in search of candidates where there is increased expression of retrocopies, rather than parental genes, in primary tumors.

Now with the fellowship funding, Yuanyuan will head back to the bench to test his hypotheses. “Through activities like DNA and histone modification, these repetitive elements are derepressed in states like cancer and aging. The question remains whether this derepression is a consequence or a cause,” says Xie.

Looking forward, Yuanyuan plans to extend the analysis to a genome-wide CRISPR screen to identify novel protein-coding and non-coding retrocopies involved in tumorigenesis. Overall these experiments seek to uncover an understudied yet potentially extensive pathological role for retrocopies in colorectal cancers wherein the mechanism may be applied to other types of cancers. These studies may help pave the road for more precise cancer therapies that specifically target retrocopies.

Off

Traditional

White

Biochemists untangle mysteries of cellular form, function

Anonymous — Thu, 25 Apr 2019 06:00:00 +0000

Biochemists untangle mysteries of cellular form, function Anonymous (not verified) Thu, 04/25/2019 - 00:00

Trent Knoss

The complex inner workings of cells, from their architecture to their signaling, underlie much of multicellular organic life. How are they built? How do their proteins interact? And most crucially, how can understanding these functions improve our knowledge of biological outcomes such as disease?

University of Colorado Boulder Distinguished Professors Karolin Luger and Natalie Ahn have studied questions such as these for decades. Last year, both were elected to the National Academy of Sciences, one of the most prestigious honors a scientist can receive. The duo will be formally inducted on Saturday, April 27 at the organization’s annual meeting.

“It’s a high honor because it comes from peers,” said Luger, the endowed chair of �� Boulder’s Department of Biochemistry and a Howard Hughes Medical Institute Investigator. “It’s primarily a wonderful acknowledgement of the collective work of all the former and present students, post-docs and technicians who have contributed to this research.”

Like an archeologist piecing together the origins of ancient structures, Luger and her students examine the fundamental building blocks of genomic processes and untangle their cellular machinery.

Luger began her career with an interest in x-ray crystallography, a technique used to discern 3D molecular structures. Eventually, her focus shifted to chromatin, the material that holds DNA, RNA and proteins together in a compact package within eukaryotic cells. As recently as the late 1980s, before the advent of the Human Genome Project, chromatin was thought to be unimportant, similar to packaging material that only serves to hold more valuable items inside.

“It was a binary mentality back then, but it turned out to be much messier, with lots of variation between individual cells,” Luger said. “The packaging, so to speak, has very important implications for how cell types differentiate.”

Imagine a space filled with labeled cardboard boxes full of books, she says. By reading the labels on the boxes, humans can discern which boxes they’ll need soon and which ones they can safely stash away. Chromatin operates similarly: A fertilized egg cell needs everything—all the genomic information it can get—whereas a more mature cell, such as a liver cell, can read the packaging and know what it can safely ignore.

Off

Traditional

White

Kristi Anseth elected to American Academy of Arts and Sciences

Anonymous — Wed, 17 Apr 2019 06:00:00 +0000

Kristi Anseth elected to American Academy of Arts and Sciences Anonymous (not verified) Wed, 04/17/2019 - 00:00

College of Engineering and Applied Science

The American Academy of Arts and Sciences announced today that �� Boulder Professor Kristi Anseth has been elected to its 2019 class. Anseth is among more than 200 individuals selected this year for their exceptional achievements in the arts and sciences, business, philanthropy and the public sector.

Founded in 1780, the American Academy of Arts and Sciences is an honorary society that recognizes and convenes leaders from a variety of disciplines to address critical issues facing the nation and the world. The academy's projects and publications inform public policy for the benefit of all.

Anseth earned her doctorate in chemical engineering from �� Boulder in 1994 and joined the faculty in 1996. Her research focuses on developing novel biomaterials for human health and advancing regenerative medicine to help prevent, treat or reverse disease and injury.

“Kristi Anseth has been on the forefront of biomaterials research for the past two decades,” said Charles Musgrave, chair of the Department of Chemical and Biological Engineering. “Her pioneering work has led the field by applying the principles of chemical engineering to the development of engineered tissues that could someday be key technologies in regenerative medicine. Her election to the American Academy of Arts and Sciences is another well-deserved recognition of her many contributions to this important field of research.”

Anseth joins at least 30 current or former �� Boulder faculty members in the Academy and is the first from the College of Engineering and Applied Science to be inducted.

Off

Traditional

White

Orit Peleg Wings HFSP Young Investigator Award

Anonymous — Thu, 28 Mar 2019 19:26:19 +0000

Orit Peleg Wings HFSP Young Investigator Award Anonymous (not verified) Thu, 03/28/2019 - 13:26

HFSP

Congrats to Orit Peleg on the announcement of her Human Frontier Science Program Young Investigator Award for the dynamics of information flow in a social network of mutually shading plants project!

The International Human Frontier Science Program Organization (HFSPO) announced today some $35 million to support the top 4% of the HFSP Research Grant applications over the coming 3 years. The 34 winning teams of the 2019 competition for the Research Grants went through a rigorous year-long selection process in a global competition that started with 814 submitted letters of intent involving scientists with their laboratories in more than 60 different countries. This year, 9 Young Investigator Grants and 25 Program Grants were selected for funding. Each team member receives on average $110,000 - $125,000 per year for 3 years.

HFSP's collaborative Research Grants are given for a broad range of projects under the umbrella theme "Complex mechanisms of living organisms". The program funds only cutting-edge, risky projects and it is the only international program that funds teams of scientists globally "without borders". HFSP Program Grants appeal to the innovative and creative potential of the research teams. Frontier life science knows no limits as winning teams propose, for example, to investigate fluid trade in hyphal networks extending from the soil into plants, seasonal reversible changes in brain size in shrews, or to image memory storage in the octopus brain.

The HFSP Young Investigator Grants are for applicants within 5 years of establishing their independent research group and no more than 10 years from their doctoral degree. This group of investigators also challenges intriguing concepts such as paradoxical responses of the immune system following injuries, or trying to understand fear generalization across different scales in the brain.

The 2019 HFSP investigators display remarkable depth in approach and innovative thinking as they start their intercontinental collaborations. The lists of all 2019 HFSP awards are available at http://www.hfsp.org/awardees/newly-awarded.

Off

Traditional

White

Dan Larremore Receives DoD Minerva Research Initiative Award

Anonymous — Tue, 26 Mar 2019 06:00:00 +0000

Dan Larremore Receives DoD Minerva Research Initiative Award Anonymous (not verified) Tue, 03/26/2019 - 00:00

The Department of Defense continued its history of strong support for fundamental research by selecting 12 faculty investigators for awards through the FY2018 Minerva Research Initiative.

This initiative supports basic research that focuses on topics of particular relevance to U.S. national security. Through its network of faculty investigators, the Minerva Research Initiative also strengthens the department’s connections with the social science community and helps DOD better understand and prepare for future challenges, including National Defense Strategy priorities such as great power competition.

Off

Traditional

White

2 researchers awarded 2019 Sloan Research Fellowships

Anonymous — Tue, 19 Feb 2019 07:00:00 +0000

2 researchers awarded 2019 Sloan Research Fellowships Anonymous (not verified) Tue, 02/19/2019 - 00:00

Assistant Professors Edward Chuong (left) and Sandeep Sharma. Photo: �� Boulder

�� Boulder assistant professors Edward Chuong and Sandeep Sharma have been awarded prestigious Sloan Research Fellowships for 2019, one of the highest honors for early-career researchers.

The fellowships, awarded yearly by the Alfred P. Sloan Foundation since 1955, mark Chuong and Sharma as among the most promising researchers in their fields. The 2019 recipients include 126 scientists from across 57 research institutions in the U.S. and Canada.

“I’m very pleased to represent �� Boulder with this award,” said Sharma, an assistant professor in the Department of Chemistry. “I’m grateful to my senior colleagues, many of whom have been very supportive and helped me build a strong, thriving lab group.”

Sharma’s research focuses on developing algorithms to perform computer simulations that can help understand and predict the unusual and intriguing properties of quantum materials and enzymes. This will potentially help in the development of materials for high-density computer memory, quantum qubits and efficient catalysts.

Edward Chuong, an assistant professor of Molecular Cellular and Developmental Biology, studies ancient genetic parasites known as “transposons,” which latch on to a host’s DNA and replicate themselves throughout the genome and rewire the expression of genes.

Collectively, the virus-like bits of genetic material constitute about 50 percent of the human genome sequence, and they are believed to have—over tens of millions of years—played a key role in the evolution of gene networks controlling immunity and development.

“We are interested not only in how these transposons have influenced our biology and helped us adapt as a species, but also in how they may contribute to disease today,” he said. “This grant provides much needed support for that line of inquiry.”

Chuong, who is also an evolutionary geneticist with the BioFrontiers Institute, uses modern gene-editing and computational tools to determine whether transposons have played a similar role in the evolution of other species, including mice, dogs and cows.

“Ultimately this work could help us understand what differences there are across mammals when it comes to immune response and how those differences evolved,” he said.

Open to scholars in eight scientific and technical fields—chemistry, computer science, economics, mathematics, computational and evolutionary molecular biology, neuroscience, ocean sciences, and physics—the Sloan Research Fellowships are awarded in close coordination with the scientific community. Winners receive a two-year, $70,000 fellowship to further their research.

“Sloan Research Fellows are the best young scientists working today,” said Adam F. Falk, president of the Alfred P. Sloan Foundation in a statement. “Sloan Fellows stand out for their creativity, for their hard work, for the importance of the issues they tackle, and the energy and innovation with which they tackle them. To be a Sloan Fellow is to be in the vanguard of 21st century science.”

Off

Traditional

White

Faculty in Focus: Tom Cech looks back on Nobel Prize in chemistry

Anonymous — Tue, 01 Jan 2019 06:00:00 +0000

Faculty in Focus: Tom Cech looks back on Nobel Prize in chemistry Anonymous (not verified) Mon, 12/31/2018 - 23:00

Kenna Bruner

It’s been 30 years since �� Boulder Distinguished Professor Tom Cech received the 1989 Nobel Prize in chemistry for his findings that RNA in living cells is not only a molecule that encodes information but can also function as a catalyst. His discovery laid the foundation for advances in molecular genetics and gave rise to an expanding appreciation of the roles of RNA in biology.

Among his many awards and recognitions, Cech was selected as a Howard Hughes Medical Institute (HHMI) investigator in 1988 and served as president of the Chevy Chase, Maryland-based HHMI—the nation’s largest private supporter of basic biomedical research—from 2000 to 2009, while retaining his �� Boulder faculty positions and lab. He is an HHMI investigator and the director of the �� Boulder BioFrontiers Institute and also has a faculty appointment at the �� Anschutz Medical Campus.

Off

Traditional

White

The ALSAM Foundation funds new Anschutz-Boulder collaborative research

Anonymous — Tue, 18 Dec 2018 20:20:28 +0000

The ALSAM Foundation funds new Anschutz-Boulder collaborative research Anonymous (not verified) Tue, 12/18/2018 - 13:20

Lindsay Diamond

The ALSAM Foundation, a generous long-time donor to the �� Skaggs School of Pharmacy and Pharmaceutical Sciences (SSPPS), has provided $2M of funding for collaborative grants between the SSPPS and the BioFrontiers Institute. This donation supports the Therapeutic Innovation Grants Program that allows the SSPPS on the Anschutz Medical Campus to join forces with the BioFrontiers Institute on the Boulder Campus to encourage faculty collaboration in the development of innovative projects that will advance the health and wellness of people in our communities and around the globe.

“The ALSAM Foundation has been a transformative force for the SSPPS and for advancing therapeutic innovations through two therapeutic innovations research grant programs totaling over $5M in the past three years. We are enormously grateful to the Foundation for its continuing support and look forward to the outcomes of these multidisciplinary research projects that promise new insights into diseases with the goal of developing new therapeutics,” says SSPPS Dean Ralph Altiere.

Tom Cech, Director of the BioFrontiers Institute at �� Boulder adds, “This program will stimulate our BioFrontiers faculty and students to work with our SSPPS colleagues at Anschutz to develop new therapeutics in the areas of cancer, muscle disease and diabetes.”

The Therapeutic Innovation Grants Program will foster cross-disciplinary collaboration among pharmaceutical researchers at the SSPPS and the interdisciplinary bioscientists at the BioFrontiers Institute with the goal of transforming the development of a new generation of drugs by fueling discovery and translation of new therapeutics to the clinic to achieve better health outcomes for patients and families. The funded projects will address this goal by facilitating the collaboration of the best scientific and clinical research minds in Colorado in a manner that allows rapid testing of new ideas and approaches. This year’s Therapeutic Innovation Grants Program proposals included faculty from University of Colorado entities including SSPPS, BioFrontiers Institute, School of Medicine (SOM) and School of Public Health (SPH).

The newly funded projects address critical health issues related to cancer, vaccine design, diabetes, depression and alcoholism among others. The newly funded research partnerships aim to advance discoveries from the laboratory to the clinic.

Principle Investigator | Collaborating Investigators

Natalie Ahn (BioFrontiers) | Nichole Reisdorph (SSPPS)
Jared Brown (SSPPS) | Tom Flaig (SOM), Myles Cockburn (SPH), John Adgate (SPH)
Carlos Catalano (SSPPS) | Robert Garcea (BioFrontiers), Ted Randolph (UCB)
Shaodong Dai (SSPPS) | Aaron Michels (SOM)
Dan LaBarbera (SSPPS) | Terry Fry (SOM)
Bradley Olwin (BioFrontiers) | Nichole Reisdorph (SSPPS)
Amy Palmer (BioFrontiers) | Raj Agarwal (SSPPS)
Manisha Patel (SSPPS) | Diego Restrepo (SOM), Emily Gibson (SOM)
Nichole Reisdorph (SSPPS) | Kristine Kuhn (SOM), Cathy Lozupone (SOM)
Michael Wempe (SSPPS) | Richard Johnson (SOM), B Vogeli (SOM)

Off

Traditional

White

Staff in Focus: Lindsay Diamond an Immunization Champion, says CDC

Anonymous — Tue, 04 Dec 2018 07:00:00 +0000

Staff in Focus: Lindsay Diamond an Immunization Champion, says CDC Anonymous (not verified) Tue, 12/04/2018 - 00:00

Cu Boulder Today

�� Boulder's Lindsay Diamond was named by the Centers for Disease Control and Prevention as a 2018 recipient of the Childhood Immunization Champion Award, jointly given by the CDC Foundation and the CDC. The announcement was made in April of 2018 during National Infant Immunization Week and will be celebrated this month in a private reception by Boulder County Health.

Lindsay Diamond (Photo courtesy the Daily Camera/staff photographer Matthew Jones)

According to the CDC website, the honor, which is given across the nation, is for individuals who are doing an exemplary job or going above and beyond to promote childhood immunzations in their communities. Diamond is this year's only recipient in the state of Colorado.

Diamond, who has a doctoral degree in molecular biology and is the director of communication at the BioFrontiers Institute, is cited for raising awareness―in a state that has exemption laws, allowing parents to decline immunizations for children, based on personal or religious beliefs―and making scientific information understandable and accessible through her organization, Community Immunity.

Daily Camera: Boulder County woman receives CDC Immunization Champion honor

Colorado Department of Public Health & Environment: Lindsay Diamond is Colorado’s 2018 Childhood Immunization Champion

Off

Traditional

White